Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
ChemistrySelect ; 8(4):1-10, 2023.
Article in English | Academic Search Complete | ID: covidwho-2219877

ABSTRACT

A simple, efficient and rapid one pot green synthesis of pyrano‐chromene derivatives have been realized by using water‐SDS‐neutral ionic liquid ([BMIm]Br) miceller system via sequential addition of aromatic aldehyde, malonitrile (Knoevenagel condensation) followed by 4‐hydroxy coumarin. In all cases the obtained products were produced well to excellent yields. This protocol shifts a versatile solvent‐catalyst system, which has many advantages such as eco‐friendly condition, simple workup and reuse (recycle) of post reaction waste containing sodium dodecyl sulphate and ionic liquid without loss of catalytic activity. The efficacy of the synthesised compounds as inhibitors of the SARS‐CoV‐2 main protease (Mpro) was investigated through molecular docking studies. Our study showed that most of the synthetic compounds exhibited excellent capability to block the SARS‐CoV‐2 Mpro by binding with crucial amino acid residues in catalytic pockets, compared to naturally occurring known SARS‐CoV‐2 Mpro inhibitors, flavonoids like Baicalein, Quercetin, and Quercetagetin. [ FROM AUTHOR]

2.
Daru ; 30(1): 139-152, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1889092

ABSTRACT

PURPOSE: Vortioxetine an anti-depressant FDA-drug recently reported showing better in vitro efficacy against SARS-CoV-2. METHODS: In this study, we have synthesized ten new derivatives having alkenes, alkynes, benzyl, aryl, and mixed carbamate at the N-terminal of vortioxetine. Then the binding energy and interactions with the crucial amino acid residues in the binding pocket of main protease (Mpro) of SARS-CoV-2, of reported and ten newly synthesized vortioxetine derivatives (total thirty-one) in comparison with remdesivir are analyzed and presented in this paper. RESULTS: Based on the docking scores predicted by ADV and AD, most vortioxetine derivatives showed better binding efficiency towards Mpro of SARS-CoV-2 in comparison with remdesivir (an EUA approved drug against SARS-CoV-2 Mpro) and vortioxetine. CONCLUSION: This study shows that some vortioxetine derivatives can be developed into promising drugs for COVID-19 treatment.


Subject(s)
COVID-19 Drug Treatment , SARS-CoV-2 , Antiviral Agents/pharmacology , Coronavirus 3C Proteases , Humans , Molecular Docking Simulation , Molecular Dynamics Simulation , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Vortioxetine/pharmacology
3.
RSC Adv ; 11(49): 30827-30839, 2021 Sep 14.
Article in English | MEDLINE | ID: covidwho-1510632

ABSTRACT

We report herein an operationally simple, efficient and versatile procedure for the synthesis of bis-indolylmethanes via the reaction of indoles with aldehydes or ketones in the presence of silica-supported ferric chloride under grindstone conditions. The prepared supported catalyst was characterized by SEM and EDX spectroscopy. The present protocol has several advantages such as shorter reaction time, high yield, avoidance of using harmful organic solvents during the reaction and tolerance of a wide range of functional groups. Molecular docking studies targeted toward the binding site of SARS-CoV-2 main protease (3CLpro or Mpro) enzymes were investigated with the synthesized bis-indoles. Our study revealed that some of the synthesized compounds have potentiality to inhibit the SARS-CoV-2 Mpro enzyme by interacting with key amino acid residues of the active sites via hydrophobic as well as hydrogen bonding interactions.

SELECTION OF CITATIONS
SEARCH DETAIL